BQST — Bioquest Income Statement
0.000.00%
Last trade - 00:00
HealthcareHighly SpeculativeMicro Cap
- $1.49m
- $1.66m
2013 April 30th | 2014 April 30th | 2021 April 30th | 2022 April 30th | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG |
Status: | Final | Final | Final | Final |
Revenue | ||||
Total Revenue | 0 | 0 | 0 | 0 |
Cost of Revenue | ||||
Gross Profit | — | — | -1.41 | — |
Selling / General / Administrative Expenses | ||||
Total Operating Expenses | 0.008 | 0.124 | 2.2 | 0.818 |
Operating Profit | -0.008 | -0.124 | -2.2 | -0.818 |
Gain / Loss on Sale of Assets | ||||
Total Net Non Operating Interest Income / Expense | ||||
Other Net Non Operating Costs | ||||
Net Income Before Taxes | -0.008 | -0.488 | -2.32 | -0.821 |
Provision for Income Taxes | ||||
Net Income After Taxes | -0.008 | -0.488 | -2.32 | -0.821 |
Net Income Before Extraordinary Items | ||||
Net Income | -0.008 | -0.488 | -2.32 | -0.821 |
Income Available to Common Shareholders Excluding Extraordinary Items | ||||
Income Available to Common Shareholders Including Extraordinary Items | ||||
Dilution Adjustment | ||||
Diluted Net Income | -0.008 | -0.488 | -2.32 | -0.821 |
Diluted Weighted Average Shares | ||||
Basic EPS Including Extraordinary Items | ||||
Diluted EPS Including Extraordinary Items | ||||
Diluted EPS Excluding Extraordinary Items | ||||
Normalised Income Before Taxes | ||||
Normalised Income After Taxes | ||||
Normalised Income Available to Common Shareholders | ||||
Diluted Normalised EPS | -0.032 | -1.8 | -0.281 | -0.081 |
Dividends per Share |